KMDA (Kamada Corp) Bozor qiymatining balans qiymatiga nisbati

Kamada Corp (KMDA) - korporativ logo

Kamada Ltd. (KMDA) Isroil va AQSh bilan eksklyuziv hukumat shartnomalariga tayanib, kamyob plazma asosidagi terapiyalarni ishlab chiqishda yetakchilik qilmoqda. Nuqsonsiz brend imidji va global hamjamiyatning ishonchi kompaniyaning yuqori ilmiy ekspertizasini tasdiqlaydi. Ushbu narxlar grafigi 1.71 miqdoridagi operatsion marjasi diversifikatsiyalangan xomashyo xarid qilish kanallari va transport jarayonida qat'iy harorat nazorati bilan qo'llab-quvvatlanadigan aktivning dinamikasini aks ettiradi.

Sof aktivlarga nisbatan bozor kapitallashuvi: Kamada Pharma (KMDA) 04.07.2022 - 28.10.2026 uchun
Kamada Ltd tayyor mahsulotlari

Kamada Ltd. (KMDA) biofarmatsevtika ta'minot zanjirlarining barqarorligi sof aktivlarning asosini tashkil etadi, ushbu ko'rsatkich bo'yicha ular biznesning joriy bozor narxi bilan solishtiriladi. Kompaniyaning bozor kapitalizatsiyasining uning kitob kapitalizatsiyasiga nisbatini tahlil qilish kapital sifati premiyasini baholash imkonini beradi va bozor kutuvlarining kompaniya resurslarining tasdiqlangan qiymatidan qanchalik yuqori ekanligini aniqlaydi.

Toʻgʻridan-toʻgʻri raqobatchilar

VRTX: Bozor kapitallashuvining balans qiymatiga nisbati|ALNY (alnylam.com) - Bozor kapitallashuvining balans qiymatiga nisbati|INSM: Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi UTHR|BMRN - Bozor qiymatining balans qiymatiga nisbati|Sof aktivlarga nisbatan bozor kapitallashuvi BridgeBio Corp (BBIO)|BGM: Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti cogentbio.com COGT|XERS: Bozor kapitallashuvining balans qiymatiga nisbati|KROS - Kapitallashuvning sof aktivlarga nisbati|Arcturus Pharma - Bozor kapitallashuvining balans qiymatiga nisbati|Eton Corp (ETON) - Balans qiymatiga nisbatan bozor kapitallashuvi|FULC (Fulcrum Therapeutics) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati ABEO|Bozor qiymatining balans qiymatiga nisbati Mereo BioPharma (MREO)|Bozor qiymatining balans qiymatiga nisbati Protalix BioTherapeutics Inc. (PLX)|Bozor kapitallashuvining balans qiymatiga nisbati PLRX|APLT - Balans qiymatiga nisbatan bozor kapitallashuvi|Kapitallashuvning sof aktivlarga nisbati Rein Therapeutics Inc|GELS - Sof aktivlarga nisbatan bozor kapitallashuvi|Bozor kapitallashuvining balans qiymatiga nisbati AYTU|Chemomab Therapeutics Ltd. (CMMB) - Bozor qiymatining balans qiymatiga koeffitsiyenti|Bozor kapitallashuvining balans qiymatiga nisbati SRx Health Solutions Inc (SRXH)|Kapitallashuvning balans qiymatiga nisbati Polyrizon Ltd. (PLRZ)|Aeterna Zentaris (AEZS) - Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor qiymati CYTH (cyclotherapeutics.com)|Inozyme Pharma (INZY) - Bozor qiymatining balans qiymatiga nisbati|Sof aktivlarga nisbatan bozor kapitallashuvi Reneo Pharmaceuticals Inc. RPHM|Bozor kapitallashuvining balans qiymatiga nisbati Aeterna Zentaris (CSCI)